New imaging test for invasive lobular breast cancer that has spread
Part of Cancer, Skin clinical trials.
This trial tests a new imaging agent, [68Ga]Ga DOTA-5G, to see if it can better detect invasive lobular breast cancer that has spread to other parts of the body. It involves a PET/CT scan and may help doctors understand the extent of your cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have been diagnosed with invasive lobular breast cancer that has spread to other parts of your body (stage IV).
- You can provide a sample of your tumor from a previous biopsy or surgery.
- You are able to lie still for up to 60 minutes for the scan.
- Your blood counts and kidney/liver function are within certain levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new approach that first uses a special scan to find cancer cells that have a specific marker, then delivers targeted radiation to those cells. It is designed for people with advanced solid tumors that have spread and stopped responding to standard treatments.
This trial tests a new targeted radioactive drug that seeks out a specific marker on lung cancer cells. It first uses a low-dose imaging scan to see if the cancer cells have this marker, then gives a higher-dose treatment to destroy those cells.
This trial tests a new type of PET scan using a special tracer (FAPI) to find cancer spread in people with lobular breast cancer when the standard scan was not clear. The goal is to see if this scan can spot more metastatic lesions, which may help guide treatment.
This study tests whether a special PET scan can better detect invasive lobular breast cancer that has spread. It may help doctors see the cancer more clearly and guide treatment decisions.
This study looks at how well imaging scans and blood tests can show where invasive lobular breast cancer has spread in the body. It may help doctors better understand and monitor this type of cancer.
This trial tests a new PET scan that uses a special tracer to find breast cancer that has spread. The scan may help doctors better see where the cancer is and guide treatment.
Hear when a new Metastatic Lobular Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.